Methyl 4-Phenoxybenzoate - CAS 21218-94-0
Catalog: |
BB056603 |
Product Name: |
Methyl 4-Phenoxybenzoate |
CAS: |
21218-94-0 |
Synonyms: |
Methyl 4-phenoxybenzoate; 4-Phenoxybenzoic acid methyl ester; 4-Phenoxy-benzoic acid methyl ester; Benzoic acid, 4-phenoxy-, methyl ester; Benzoic acid, p-phenoxy-, methyl ester; Methyl4-phenoxybenzoate; Methyl p-phenoxybenzoate |
IUPAC Name: | methyl 4-phenoxybenzoate |
Description: | Methyl 4-Phenoxybenzoate is useful for preparing potential InhA reductase inhibitors. |
Molecular Weight: | 228.24 |
Molecular Formula: | C14H12O3 |
Canonical SMILES: | COC(=O)C1=CC=C(C=C1)OC2=CC=CC=C2 |
InChI: | InChI=1S/C14H12O3/c1-16-14(15)11-7-9-13(10-8-11)17-12-5-3-2-4-6-12/h2-10H,1H3 |
InChI Key: | XMXLYEKPSHVLKD-UHFFFAOYSA-N |
References: | Ibrahim, T. S., et al. Molecules, 25, 3125 (2020). |
GHS Hazard Statement: | H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin] |
Precautionary Statement: | P261, P272, P280, P302+P352, P321, P333+P313, P362+P364, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2020270463-A1 | Modified graphene, method of producing modified graphene, modified graphene-resin composite, modified graphene sheet, and modified graphene dispersion | 20190227 |
CN-107652294-A | A kind of preparation method of Ibrutinib | 20171114 |
AU-2018349293-A1 | Novel phenylpyridine derivative and pharmaceutical composition comprising the same | 20171011 |
CA-3076667-A1 | Phenylpyridine derivative and pharmaceutical composition comprising the same | 20171011 |
CN-111212833-A | Novel phenylpyridine derivative and pharmaceutical composition comprising same | 20171011 |
KR-20190040773-A | Novel phenyl pyridine derivatives and pharmaceutical composition comprising the same | 20171011 |
WO-2019074275-A1 | NEW 1H-PYRAZOLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | 20171011 |
AU-2018349293-B2 | Novel phenylpyridine derivative and pharmaceutical composition comprising the same | 20171011 |
BR-112020007177-A2 | innovative phenylpyridine derivatives and pharmaceutical composition comprising the same | 20171011 |
EP-3696176-A1 | Novel phenylpyridine derivative and pharmaceutical composition containing same | 20171011 |
Complexity: | 238 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 228.078644241 |
Formal Charge: | 0 |
Heavy Atom Count: | 17 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 228.078644241 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 35.5Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.6 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[104517-96-6]
Ioversol related compound B
-
[33229-34-4]
2,2'-[4-(2-Hydroxyethylamino)-3-nitrophenylimino]diethanol
-
[582-16-1]
2,7-Dimethylnaphthalene
-
[16208-48-3]
Ethanesulfonic acid, 2,2'-trithiodi-, disodium salt
-
[30879-49-3]
2'-Nitro-5'-hydroxyacetophenone
INDUSTRY LEADERS TRUST OUR PRODUCTS